Ozempic, Wegovy users sue over rare, permanent blindness

More than 200 federal lawsuits have been filed by users of GLP-1 drugs, specifically Ozempic and Mounjaro. The legal actions allege that these medications caused NAION, which is a rare condition leading to permanent blindness. While the plaintiffs claim the drugs are responsible for this severe vision loss, the manufacturers are currently disputing these allegations. The litigation focuses on the link between the use of these specific medications and the onset of permanent ocular damage.